Heritage Bio Labs
Research Library
Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.
Find articles
All articles
Showing 37–48 of 411 articles
- Explore study findings
What a 2026 retraction changed about kidney research
ARA-290, also called cibinetide or pyroglutamate helix B surface peptide, is an 11-amino-acid experimental peptide designed from the shape of erythropoietin. A February 2026 journal notice changed how researchers should read one older study of the peptide in an animal model of acute kidney injury.
ARA-2902 sources (2008, 2026)
- Explore study findings
Why a sarcoidosis trial photographed nerves in the cornea
ARA-290, or cibinetide, is a synthetic 11-amino-acid peptide designed to engage a proposed tissue-protection signaling pathway. Researchers studying small nerve fibers in sarcoidosis needed a way to measure tissue changes in living people.
ARA-2902 sources (2017, 2026)
- Explore study findings
What the eye study found beyond a nerve image
ARA-290, called cibinetide in a 2020 eye study, is an 11-amino-acid peptide designed from erythropoietin. That older phase 2 pilot asked whether the peptide would affect diabetic macular edema, in which fluid accumulates in the central retina.
ARA-2902 sources (2017, 2020)
- Interpret the evidence
How the diabetes trial separated symptoms from glucose markers
ARA-290 is an experimental 11-amino-acid peptide designed from erythropoietin to study tissue responses without reproducing its red-blood-cell stimulus.
ARA-2902 sources (2008, 2015)
- Understand the science
How a folded protein inspired an eleven-amino-acid peptide
ARA-290, also called cibinetide, is an 11-amino-acid example derived from the shape of erythropoietin. A foundational 2008 study asked whether part of that protein's surface could reproduce certain tissue responses while leaving red-blood-cell production unstimulated in the experiments.
ARA-2901 source (2008)
- Check methods and identity
What a diabetic mouse wound model could measure
ARA-290, also known as cibinetide, is a designed 11-amino-acid peptide modeled on a surface of erythropoietin. An older laboratory study, first published online in 2017, investigated how wounds in mice with genetic diabetes responded to the peptide.
ARA-2901 source (2017)
- Explore study findings
What the October 2026 compounding notice covers
BPC-157 is a synthetic 15-amino-acid peptide investigated in tissue injury models. In October 2026, the U.S. Department of Health and Human Services published a notice about an interim policy on certain peptide bulk drug substances.
BPC-1572 sources (2026)
- Check methods and identity
What a 2026 rat experiment measured after blood flow returned
BPC-157 is a synthetic peptide containing 15 amino acids. In May 2026, researchers reported an experiment that asked whether it changed early signs of damage when blood flow returned to a rat's hind limb after a temporary interruption.
BPC-1571 source (2026)
- Explore study findings
What isolated human artery rings can reveal
BPC-157 is a synthetic chain of 15 amino acids being studied in vascular and tissue injury experiments. In May 2026, a laboratory study used pieces of human artery to ask whether BPC-157 affected vessel tension and whether the artery's inner lining contributed to the response.
BPC-1571 source (2026)
- Check methods and identity
How a registered hamstring study plans to measure recovery
BPC-157 is an experimental 15-amino-acid peptide. A clinical trial registered in February 2026 proposes to study it in people with acute grade II hamstring strains confirmed by magnetic resonance imaging.
BPC-1571 source (2026)
- Understand the science
How scientists tracked the intact peptide in animals
BPC-157 is a synthetic 15-amino-acid peptide. In an older 2022 study, researchers examined how long the intact molecule remained in animal blood and what happened to its components as it was processed. The investigators measured BPC-157 in rats and beagle dogs.
BPC-1571 source (2022)
- Understand the science
How two rat tendon studies used different injury models
BPC-157 is a synthetic 15-amino-acid peptide studied in tendon injury models. An older experiment tested it after cutting rat Achilles tendons, while a July 2026 study also sutured the cut tendon. Comparing the models shows why details of the injury and repair matter when scientists measure healing.
BPC-1572 sources (2003, 2026)
Browse by product
- A4 Amyloid Beta6 articles
- ACE-0316 articles
- ACE-0836 articles
- Adipotide6 articles
- AICAR6 articles
- AOD-96046 articles
- ARA-2906 articles
- BPC-1576 articles
- BPC-157 / TB-5006 articles
- Cagrilintide7 articles
- CJC-1295 (No DAC) / GHRP-26 articles
- CJC-1295 (No DAC) / GHRP-66 articles
- CJC-1295 (No DAC) / Ipamorelin6 articles
- CJC-1295 No DAC6 articles
- CJC-1295 With DAC6 articles
- DSIP6 articles
- Epitalon6 articles
- Follistatin 3156 articles
- Follistatin 3446 articles
- Fragment 176-1916 articles
- GHK-Cu6 articles
- GHRP-26 articles
- GHRP-66 articles
- GLOW 2 Blend6 articles
- GLOW Blend6 articles
- GLP-1 SEMA6 articles
- GLP-2 TIRZ6 articles
- Glutathione6 articles
- HCG6 articles
- Hexarelin6 articles
- Human Relaxin-26 articles
- IGF-1 DES 1,36 articles
- IGF-1 Human6 articles
- IGF-2 LR36 articles
- IGF-DES 1,36 articles
- IGF-LR36 articles
- Ipamorelin6 articles
- Kisspeptin-106 articles
- KLOW Blend6 articles
- KPV6 articles
- Lipopeptide6 articles
- Liraglutide6 articles
- Melanotan II5 articles
- MGF6 articles
- MOTS-C6 articles
- MSC Exosomes6 articles
- Myostatin6 articles
- Myostatin HMP (GDF8)6 articles
- Oxytocin7 articles
- PEG-MGF6 articles
- Pinealon6 articles
- PT-1416 articles
- RETA / IGF-1 LR36 articles
- RETA GLP-36 articles
- Selank6 articles
- SEMA / IGF-1 LR36 articles
- Semax6 articles
- Sermorelin6 articles
- SLU-PP-3326 articles
- SNAP-86 articles
- Survodutide7 articles
- TB-5006 articles
- Tesamorelin6 articles
- Thymosin Alpha-16 articles
- TIRZ / IGF-1 LR36 articles
- TIRZ GLP-26 articles
- Trevogrumab6 articles
- Triptorelin GnRH6 articles
